Oxidative Stress:

This blog post deals about the oxidative stress discovered by OXIS International, Inc. is engaged in the research, development and sale of products that counteract the harmful effects of “oxidative stress.” We focus on naturally occurring protective substances since they are more likely to be both safe and efficacious. Our primary products incorporate and emphasize the multifaceted “super antioxidant” compound, L-­Ergothioneine (“ERGO”), as a key component. We own several patents and pending applications related to ERGO that cover current and planned products relevant to our nutraceutical and cosmecuetical businesses. Our patents and patent applications address ERGO’s protective effects and activities and the ERGO manufacturing process.

We focus on naturally occurring protective substances since they are more likely to be both safe and efficacious. Our primary products incorporate and emphasize the multifaceted “super antioxidant” compound, L-Ergothioneine (“ERGO”), as a key component. We own several patents and pending applications related to ERGO that cover current and planned products relevant to our nutraceutical and cosmecuetical businesses. Our patents and patent applications address ERGO’s protective effects and activities and the ERGO manufacturing process.
http://www.oxis.com
Oxis on Twitter
Oxis on facebook

Not stressing over their therapies. Founded in 1965 and headquartered in Portland, OR, OXIS International, Inc is a provider of diagnosis and treatment services for oxidative stress-related diseases. Diagnostic assays and drug monitoring assays produced by its subsidiary, OXIS Health Products, make up the bulk of its sales. Its BXT-51072 product is currently undergoing trials, an d is likely to treat inflammatory bowel disease.